Palo Alto Investors LP Vanda Pharmaceuticals Inc. Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $192,976 - $296,228	-45,088 Reduced 13.91%	278,985 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $935,881 - $1.1 Million	-158,624 Reduced 32.86%	324,073 $2.14 Million
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $3.74 Million - $4.83 Million	-604,910 Reduced 55.62%	482,697 $3.28 Million
Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $7.41 Million - $11.8 Million	-1,078,549 Reduced 49.79%	1,087,607 $8.04 Million
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $3.07 Million - $3.82 Million	-325,044 Reduced 13.05%	2,166,156 $21.4 Million
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $3.72 Million - $5.68 Million	-343,044 Reduced 12.1%	2,491,200 $28.2 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $15 Million - $20.2 Million	-957,561 Reduced 25.25%	2,834,244 $44.5 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $5.89 Million - $8.9 Million	-438,743 Reduced 10.37%	3,791,805 $57 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $588,808 - $832,287	60,267 Added 1.45%	4,230,548 $55.6 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $500,791 - $645,870	53,733 Added 1.31%	4,170,281 $40.3 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $176,758 - $219,941	-18,298 Reduced 0.44%	4,116,548 $47.1 Million
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $2.93 Million - $6.56 Million	-390,630 Reduced 8.63%	4,134,846 $42.8 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $689,566 - $973,078	-55,700 Reduced 1.22%	4,525,476 $74.3 Million
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $5.81 Million - $7.48 Million	-473,874 Reduced 9.37%	4,581,176 $60.8 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $15.8 Million - $27.9 Million	899,380 Added 21.64%	5,055,050 $93 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $64 Million - $78.3 Million	4,155,670	4,155,670 $74.4 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$15.8 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.3 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.86 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account